Skip to main content

Table 2 Univariate analysis of lymph node recurrence-free survival (LN-RFS) and distant recurrence-free survival (DRFS) in patients with papillary thyroid carcinoma (PTC) (months, mean ± SE)

From: High ALDH1A1 expression correlates with poor survival in papillary thyroid carcinoma

Variable

Case

LN-RFS

P

DRFS

P

Gender

     

Female

158

63.0 ± 2.0

0.073

72.1 ± 1.6

0.362

Male

89

69.3 ± 2.3

 

72.9 ± 1.8

 

Age

     

< 45

139

65.3 ± 1.7

0.172

73.4 ± 1.5

0.216

> 45

108

64.9 ± 2.4

 

71.1 ± 1.9

 

EI

     

No

174

66.7 ± 1.7

0.036

73.4 ± 1.2

0.028

Yes

73

    

PT status

     

1

85

60.4 ± 3.4

0.017

68.1 ± 2.9

0.032

2

64

69.4 ± 2.1

 

74.1 ± 2.8

 

3

82

   

4

16

66.2 ± 1.8

 

70.3 ± 2.3

65.9 ± 1.3

 

69.4 ± 1.8

60.3 ± 2.5

 

63.5 ± 2.7

PN status

     

0

171

66.9 ± 1.7

0.028

73.3 ± 1.2

0.046

1

76

60.2 ± 3.2

 

68.6 ± 2.9

 

TNM

     

1 to 2

133

68.4 ± 2.2

0.047

75.1 ± 1.6

0.012

3 to 4

114

60.6 ± 1.9

 

64.7 ± 1.6

 

ALDH1A1

     

Low

116

69.5 ± 2.1

0.007

75.3 ± 1.2

0.008

High

131

61.6 ± 2.2

 

69.8 ± 1.9

 
  1. ALDH1A1 (low, the low expression of ALDH1A1; high, the high expression of ALDH1A1) EI, extrathyroid invasion.